JMCCX
Price
$58.64
Change
-$0.25 (-0.42%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

JMCCX vs VMCPX

Header iconJMCCX vs VMCPX Comparison
Open Charts JMCCX vs VMCPXBanner chart's image
JPMorgan Mid Cap Equity C
Price$58.64
Change-$0.25 (-0.42%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JMCCX vs VMCPX Comparison Chart
Loading...
VS
JMCCX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMCCX is a StrongBuy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. JMCCX (4.71B). VMCPX pays higher dividends than JMCCX: VMCPX (1.51) vs JMCCX (0.00). JMCCX was incepted earlier than VMCPX: JMCCX (15 years) vs VMCPX (14 years). JMCCX is a more actively managed with annual turnover of: 40.00 vs. VMCPX (13.00). JMCCX has a lower initial minimum investment than VMCPX: JMCCX (1000) vs VMCPX (100000000). VMCPX (25.17) and JMCCX (24.37) have marching annual gain over last year. VMCPX return over 5 years is better than : 56.93 vs. JMCCX (21.77).
JMCCXVMCPXJMCCX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years14 years-
Gain YTD11.01912.59387%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.71B172B3%
Annual Yield % from dividends0.001.51-
Returns for 1 year24.3725.1797%
Returns for 3 years1.249.8513%
Returns for 5 years21.7756.9338%
Returns for 10 years34.85128.7527%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals